Wang Q, Cai B, Zhong L, Intirach J, Chen T
Diabetol Metab Syndr. 2024; 16(1):59.
PMID: 38438892
PMC: 10913216.
DOI: 10.1186/s13098-024-01299-8.
Mai A, Tan B, Sun Q, Tan E
J Clin Med. 2024; 13(2).
PMID: 38256693
PMC: 10816052.
DOI: 10.3390/jcm13020561.
Choi J, Han K, Kim Y, Lee S, Shin J, Yang S
Gerontology. 2023; 69(11):1269-1277.
PMID: 37640013
PMC: 10634271.
DOI: 10.1159/000533676.
Gialluisi A, De Bartolo M, Costanzo S, Belvisi D, Falciglia S, Ricci M
J Neurol. 2023; 270(9):4487-4497.
PMID: 37294324
DOI: 10.1007/s00415-023-11803-1.
Wullner U, Borghammer P, Choe C, Csoti I, Falkenburger B, Gasser T
J Neural Transm (Vienna). 2023; 130(6):827-838.
PMID: 37169935
PMC: 10174621.
DOI: 10.1007/s00702-023-02635-4.
Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis.
Zhong Q, Wang S
Front Aging Neurosci. 2023; 15:1109914.
PMID: 37009459
PMC: 10060805.
DOI: 10.3389/fnagi.2023.1109914.
Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
Chen H, Wang C, Chen H, Liou H
PLoS One. 2022; 17(8):e0269006.
PMID: 35951654
PMC: 9371359.
DOI: 10.1371/journal.pone.0269006.
Patients with Parkinson's disease predict a lower incidence of colorectal cancer.
Fang H, Du Y, Pan S, Zhong M, Tang J
BMC Geriatr. 2021; 21(1):564.
PMID: 34663210
PMC: 8522030.
DOI: 10.1186/s12877-021-02497-z.
Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Qin X, Zhang X, Li P, Wang M, Yan L, Bao Z
Front Neurol. 2021; 12:678649.
PMID: 34349721
PMC: 8326375.
DOI: 10.3389/fneur.2021.678649.
Association between diabetes mellitus and risk of Parkinson's disease: A prisma-compliant meta-analysis.
Liu W, Tang J
Brain Behav. 2021; 11(8):e02082.
PMID: 34291588
PMC: 8413776.
DOI: 10.1002/brb3.2082.
Case-control study of hypertension and Parkinson's disease.
Ng Y, Ng E, Lim E, Prakash K, Tan L, Tan E
NPJ Parkinsons Dis. 2021; 7(1):63.
PMID: 34290246
PMC: 8295270.
DOI: 10.1038/s41531-021-00202-w.
Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.
Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X
BMJ Open. 2021; 11(7):e046329.
PMID: 34215604
PMC: 8256737.
DOI: 10.1136/bmjopen-2020-046329.
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Chohan H, Senkevich K, Patel R, Bestwick J, Jacobs B, Ciga S
Mov Disord. 2021; 36(6):1420-1429.
PMID: 33682937
PMC: 9017318.
DOI: 10.1002/mds.28551.
Risk of Nonmelanoma Skin Cancers and Parkinson's Disease-Meta-Analysis and Systematic Review.
Krasowska D, Gerkowicz A, Mlak R, Leziak M, Malecka-Massalska T, Krasowska D
Cancers (Basel). 2021; 13(4).
PMID: 33546132
PMC: 7913207.
DOI: 10.3390/cancers13040587.
Herpesvirus Infections and Risk of Parkinson's Disease.
Camacho-Soto A, Faust I, Racette B, Clifford D, Checkoway H, Searles Nielsen S
Neurodegener Dis. 2021; 20(2-3):97-103.
PMID: 33461199
PMC: 8552529.
DOI: 10.1159/000512874.
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Camargo Maluf F, Feder D, Carvalho A
Parkinsons Dis. 2019; 2019:4951379.
PMID: 31871617
PMC: 6906831.
DOI: 10.1155/2019/4951379.
Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.
Kim Y, Lee C, Kim S, Jang J, Lee S, Lee S
J Neurol. 2019; 267(2):513-521.
PMID: 31691020
DOI: 10.1007/s00415-019-09617-1.
Understanding the links between cardiovascular disease and Parkinson's disease.
Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C
Mov Disord. 2019; 35(1):55-74.
PMID: 31483535
PMC: 6981000.
DOI: 10.1002/mds.27836.
The Relevance of Insulin Action in the Dopaminergic System.
Fiory F, Perruolo G, Cimmino I, Cabaro S, Pignalosa F, Miele C
Front Neurosci. 2019; 13:868.
PMID: 31474827
PMC: 6706784.
DOI: 10.3389/fnins.2019.00868.
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways.
Green H, Tsitsi P, Markaki I, Aarsland D, Svenningsson P
CNS Drugs. 2019; 33(2):143-160.
PMID: 30687888
PMC: 6373401.
DOI: 10.1007/s40263-018-0601-x.